Meanwhile, the NF-κB inhibitor group only exhibited a downregulation of TLR4 protein expression.<h4>Discussion</h4>Our findings demonstrated that JLD alleviated acute gouty arthritis by upregulating PPARγ expression, which subsequently inhibited the TLR4/NF-κB signaling pathway. The gene discussed is PPARG; the disease is gout.